BRCA2 and ovarian carcinoma: Having demonstrated that WRN complementation partially rescued the hyper-degradation phenotype of BRCA2-depleted cells (Fig. 1e and f), we tested the effect of WRN knockdown on nascent DNA degradation in the BRCA2-mutated ovarian cancer cell line PEO137.